NDC 62959-116 - hybrid CF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62959-116
- Manufacturer
- Hybrid-Rx LLC
- Effective date
- 2010-02-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| hybrid CF - Hybrid-Rx LLC | Hybrid-Rx LLC | 2010-02-03 | HUMAN OTC DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen Caplets | ACETAMINOPHEN | Breeden Brothers, LLC | 57fff3dc-ba30-4d3d-9362-01df6974f813 | 2017-02-15 | Warnings | 362O9ITL9D |
| Acetaminophen Diphenhydramine HCl | ACETAMINOPHEN DIPHENHYDRAMINE HCL | Chain Drug Consortium,LLC | 47f839b9-ac8a-161c-e054-00144ff8d46c | 2017-02-07 | Warnings | 362O9ITL9D |
| Cold Medicine | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Selder, S.A. de C.V. | d2762d9c-e7e7-42b2-a26a-14b2aa0307cb | 2017-01-25 | Warnings | 04JA59TNSJ V1Q0O9OJ9Z 362O9ITL9D |
| SED-MAX | ACETAMINOPHEN 500 MG WITH CAFFEINE 65MG | Command Brands, LLC | 4920a0e9-6f88-4df0-8657-77c95a3b9617 | 2017-01-19 | Warnings | 362O9ITL9D |
| Allergy Relief | CHLORPHENIRAMINE MALEATE | CVS Pharmacy | 626aa162-f5e3-45c0-b5ac-d70bff255aed | 2017-01-19 | Warnings | V1Q0O9OJ9Z |
| Allergy | CHLORPHENIRAMINE MALEATE | Marc Glassman, Inc. | 2051247f-ce64-4cf5-b449-9ca14c43ab86 | 2016-12-27 | Warnings | V1Q0O9OJ9Z |
| BRONCOCHEM EXPECTORANT II | ACETAMINOPHEN-CHLORPHENIRAMINE MALEATE-DEXTROMETHORPHAN HBR-GUAIFENESIN-PHENYLEPHRINE HCL | LABORATORIO MAGNACHEM INTERNATIONAL SRL | d0426469-9dd1-4bd1-b81e-69d33187daa2 | 2016-12-19 | Warnings | 04JA59TNSJ V1Q0O9OJ9Z 362O9ITL9D |
| CVS Health Four Actions Nasal Decongestant | PHENYLEPHRINE HYDROCHLORIDE | CVS Pharmacy,Inc. | c91b5525-6afb-4fea-afcb-9c4578075975 | 2016-09-22 | Warnings | 04JA59TNSJ |
| Butalbital, Acetaminophen, and Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Actavis Pharma, Inc. | a6cbc17f-5c60-489c-8029-84b0add556d8 | 2014-08-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| 5e3e64e8-adb5-4072-a226-732d7ca75f57 | f501f971-4712-43bc-aee7-a244d24488fb | 2010-02-03 | Warnings | 5e3e64e8-adb5-4072-a226-732d7ca75f57 f501f971-4712-43bc-aee7-a244d24488fb |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.